GlassScriptPhysician profile
Catalin Loghin
NPI 1235162215
$11,327.06
in general payments reported to CMS, 2019-2025
10 companies · $2,500 in 2025
The $2,500 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $1,250 · 2021: $895 · 2022: $2,749 · 2023: $3,250 · 2024: $192 · 2025: $2,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,123 · Honoraria: $2,500 · Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,122.88 |
| Honoraria | $2,500.00 |
| Food and Beverage | $318.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canon Medical Systems USA, INC. | $7,339.22 | 2019-2025 | Ct Scanner Epsilon |
| Ge Healthcare | $3,233.00 | 2023 | |
| Siemens Medical Solutions USA, INC. | $229.83 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $191.69 | 2024 | Gore Cardioform Septal Occluder |
| Heartflow, INC. | $138.73 | 2022 | |
| Astellas Pharma US INC | $99.00 | 2021 | |
| Medtronic, INC. | $54.73 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.96 | 2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.01 | 2019 | |
| Amgen INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catalin Loghin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.